ACADIA Pharmaceuticals Inc (ACAD) financials · P/E 15, rev $576.0M
ACADIA Pharmaceuticals Inc (ACAD) P/E 15, rev $576.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.07B | $957.8M |
| Cost of Revenue | $89.0M | $81.8M |
| Gross Profit | $982.5M | $876.0M |
| Operating Income | $104.8M | $230.8M |
| Net Income | $391.0M | $226.5M |
| EPS (Diluted) | $2.30 | $1.36 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.56B | $1.19B |
| Current Assets | $1.06B | $938.3M |
| Cash & Equivalents | $177.7M | $319.6M |
| Inventory | $111.4M | $91.7M |
| PP&E | $7.5M | $4.2M |
| Total Liabilities | $336.8M | $455.0M |
| Current Liabilities | $277.1M | $394.9M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $1.23B | $732.8M |
| Retained Earnings | -$1.81B | -$2.20B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $109.8M | $157.7M |
| CapEx | $4.7M | $523.0K |
| Investing Cash Flow | -$302.6M | -$30.5M |
| Financing Cash Flow | $49.9M | $6.8M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$142.8M | $133.9M |
| Free Cash Flow | $105.1M | $157.2M |
FAQ
What is ACAD P/E and revenue?
ACADIA Pharmaceuticals Inc (ACAD) P/E 15, rev $576.0M.
What is ACAD revenue?
ACADIA Pharmaceuticals Inc last cached revenue is $1.07B (FY2025).
Is ACAD profitable?
ACADIA Pharmaceuticals Inc last cached net income is $391.0M.
What are ACAD total assets?
ACADIA Pharmaceuticals Inc last cached total assets are $1.56B.
What is ACAD free cash flow?
ACADIA Pharmaceuticals Inc last cached free cash flow is $105.1M.
Not investment advice. Cached statements, not a live tape.